Skip to main content

Advertisement

Table 3 Baseline characteristics of non-PCOS and PCOS without HA participants

From: PCOS without hyperandrogenism is associated with higher plasma Trimethylamine N-oxide levels

 ControlPCOS-NP-Value
IFN-α (pg/ml)3.02 (2.53–4.61)3.11 (1.94–4.15)0.763
IFN-γ (pg/ml)4.16 (3.03–5.70)4.52 (3.61–5.99)0.477
TNF-α (pg/ml)3.34 (2.27–3.44)3.24 (2.19–3.54)0.646
MCP-1 (pg/ml)154.38 (94.27–218.21)167.53 (130.18–197.62)0.613
IL-6 (pg/ml)3.78 (3.66–7.90)3.93 (3.66–9.23)0.362
IL-8 (pg/ml)11.47 (9.01–16.01)11.03 (9.30–14.41)0.603
IL-10 (pg/ml)5.99 (3.72–7.66)4.69 (3.76–8.07)0.837
IL-17A (pg/ml)1.89 (1.08–1.94)1.92 (1.34–2.29)0.179
IL-18 (pg/ml)272.61 (177.57–377.55)310.25 (209.55–490.93)0.521
IL-33 (pg/ml)37.71 (18.84–45.74)31.60 (12.77–49.29)0.785
Plasma TMAO (μmol/L)1.65 (1.01–2.38)2.37 (1.77–5.78)0.003*
  1. Data are presented as median (interquartile range). (*) represents significant difference between groups, p < 0.01; (**) represents significant difference between groups, p < 0.0001. IFN-α Interferon alpha, IFN-γ Interferon gamma, TNF-α Tumor necrosis factor alpha, MCP-1 Monocyte chemoattractant protein-1, IL-6 Interleukin 6, IL-8 Interleukin 8, IL-10 Interleukin 10, IL-17A Interleukin 17A, IL-18 Interleukin 18, IL-33 Interleukin 33, TMAO Trimethylamine N-oxide